Loading patent…
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsIra H. Pastan, Mark C. Willingham
Estimating the term…
The entry of animal viruses into their host cells proceeds via a specialized internalization pathway involving clathrin coated regions of the plasma membrane. In the present invention, there has been examined the effect of dansylcadaverine compared with amantadine and other antiviral agents as to the entry of vesicular stomatitis virus (VSV) into mouse cells. It was found that both compounds inhibit VSV entry. Both compounds inhibit the uptake of .alpha..sub.2 macroglobulin (.alpha.2M), a protein that binds to specific membrane receptors and follows the same route of internalization. Dansylcadaverine is 20 fold more potent than amantadine to the blocking virus and also to the .alpha..sub.2 macroglobulin uptake.
A method of inhibiting and blocking the effective entry of vesicular stomatitis virus (VSV) and .alpha..sub.2 macroglobulin (.alpha..sub.2 M) into mouse cells comprising administering thereto an effective blockading amount of ##STR2## R.sub.1 =--(CH.sub.2)--.sub.3-7 R.sub.2 =--CH.sub.3
Dependencies are inferred from the claim text.